| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Richard Sutton | |
| P2860 | cites work | "Cardioneuroablation"--new treatment for neurocardiogenic syncope, functional AV block and sinus dysfunction using catheter RF-ablation | Q33152292 |
| Hospital admission of patients referred to the Emergency Department for syncope: a single-hospital prospective study based on the application of the European Society of Cardiology Guidelines on syncope | Q33153024 | ||
| The clinical impact of implantable loop recorders in patients with syncope | Q33153340 | ||
| A controlled trial of acute and long-term medical therapy in tilt-induced neurolly mediated syncope | Q33153356 | ||
| Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope | Q33153607 | ||
| Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope | Q33153669 | ||
| Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial). | Q33154371 | ||
| Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years | Q33154430 | ||
| Is vasovagal syncope a disease? | Q33154755 | ||
| Clinical predictors of cardiac syncope at initial evaluation in patients referred urgently to a general hospital: the EGSYS score | Q33156328 | ||
| Pacing in elderly recurrent fallers with carotid sinus hypersensitivity: a randomised, double-blind, placebo controlled crossover trial | Q33156986 | ||
| Syncope prevalence in the ED compared to general practice and population: a strong selection process | Q33157245 | ||
| Can benign etiologies predict benign outcomes in high-risk syncope patients? | Q33158075 | ||
| Carotid sinus syndrome, should we pace? A multicentre, randomised control trial (Safepace 2). | Q33158082 | ||
| Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry. | Q33159486 | ||
| Amnesia for loss of consciousness is common in vasovagal syncope | Q33159860 | ||
| Standardized approaches to the investigation of syncope: Canadian Cardiovascular Society position paper | Q33159888 | ||
| Catheter ablation of severe neurally meditated reflex (neurocardiogenic or vasovagal) syncope: cardioneuroablation long-term results | Q33160189 | ||
| Syncope in the emergency department: comparison of standardized admission criteria with clinical practice | Q33160243 | ||
| Additional diagnostic value of very prolonged observation by implantable loop recorder in patients with unexplained syncope | Q33160268 | ||
| Endocardial autonomic denervation of the left atrium to treat vasovagal syncope: an early experience in humans | Q33160900 | ||
| Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial | Q33161271 | ||
| Key challenges in the current management of syncope | Q33161543 | ||
| Syncope diagnostic scores | Q33162480 | ||
| The semiology of tilt-induced psychogenic pseudosyncope | Q33163063 | ||
| Clinical context and outcome of carotid sinus syndrome diagnosed by means of the 'method of symptoms'. | Q33163309 | ||
| Ivabradine in treatment of sinus tachycardia mediated vasovagal syncope | Q33163325 | ||
| Randomized clinical trial of an emergency department observation syncope protocol versus routine inpatient admission | Q33163526 | ||
| Benefit of pacemaker therapy in patients with presumed neurally mediated syncope and documented asystole is greater when tilt test is negative: an analysis from the third International Study on Syncope of Uncertain Etiology (ISSUE-3). | Q33163622 | ||
| Physical counter-pressure manoeuvres in preventing syncopal recurrence in patients older than 40 years with recurrent neurally mediated syncope: a controlled study from the Third International Study on Syncope of Uncertain Etiology (ISSUE-3)†. | Q33164403 | ||
| Twenty-eight years of research permit reinterpretation of tilt-testing: hypotensive susceptibility rather than diagnosis | Q33164469 | ||
| History taking as a diagnostic test in patients with syncope: developing expertise in syncope | Q33165066 | ||
| Clinical history in management of suspected syncope: A powerful diagnostic tool | Q33165087 | ||
| Assessment of a standardized algorithm for cardiac pacing in older patients affected by severe unpredictable reflex syncopes | Q33165520 | ||
| Syncope Unit: rationale and requirement--the European Heart Rhythm Association position statement endorsed by the Heart Rhythm Society | Q33165904 | ||
| The benefit of a remotely monitored implantable loop recorder as a first line investigation in unexplained syncope: the EaSyAS II trial | Q33166336 | ||
| Great expectations: what patients with unexplained syncope desire | Q33166471 | ||
| Cardiac output and vasodilation in the vasovagal response: An analysis of the classic papers | Q33166482 | ||
| Standardized algorithm for cardiac pacing in older patients affected by severe unpredictable reflex syncope: 3-year insights from the Syncope Unit Project 2 (SUP 2) study | Q33166495 | ||
| Diagnostic role of head-up tilt test in patients with cough syncope | Q33166703 | ||
| Long-term cardiac monitoring in older adults with unexplained falls and syncope | Q33166749 | ||
| Fludrocortisone for the Prevention of Vasovagal Syncope: A Randomized, Placebo-Controlled Trial | Q33167359 | ||
| Stop vasodepressor drugs in reflex syncope: a randomised controlled trial | Q33167724 | ||
| Mechanisms of Vasovagal Syncope in the Young: Reduced Systemic Vascular Resistance Versus Reduced Cardiac Output | Q33168157 | ||
| Head-up tilt: a useful test for investigating unexplained syncope | Q33168914 | ||
| Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results | Q33173519 | ||
| A positive response to head-up tilt testing predicts syncopal recurrence in carotid sinus syndrome patients with permanent pacemakers | Q33173598 | ||
| Psychogenic syncope diagnosed by prolonged head-up tilt testing. | Q33173785 | ||
| Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo. | Q33173828 | ||
| Permanent pacing for cardioinhibitory malignant vasovagal syndrome | Q33174143 | ||
| Midodrine: a role in the management of neurocardiogenic syncope. | Q33175537 | ||
| The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope | Q33175949 | ||
| 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice | Q34319426 | ||
| High diagnostic yield and accuracy of history, physical examination, and ECG in patients with transient loss of consciousness in FAST: the Fainting Assessment study | Q34698640 | ||
| High Remission Rates in Vasovagal Syncope: Systematic Review and Meta-Analysis of Observational and Randomized Studies | Q88667972 | ||
| Guidelines for the diagnosis and management of syncope (version 2009) | Q24622801 | ||
| Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study | Q32055138 | ||
| Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause | Q33145603 | ||
| Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope : pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators | Q33145604 | ||
| Syncope and seizures of psychogenic origin: identification with head-upright tilt table testing | Q33145733 | ||
| The relationship between health-related quality of life and frequency of spells in patients with syncope | Q33146029 | ||
| Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy | Q33146536 | ||
| Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. | Q33146537 | ||
| Guidelines on management (diagnosis and treatment) of syncope. | Q33146619 | ||
| Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study | Q33146717 | ||
| Carotid sinus syndrome: a modifiable risk factor for nonaccidental falls in older adults (SAFE PACE). | Q33147006 | ||
| Results and complications of the carotid sinus massage performed according to the "method of symptoms". | Q33147425 | ||
| Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being | Q33147928 | ||
| Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study | Q33148062 | ||
| Long-term follow-up results of tilt training therapy in patients with recurrent neurocardiogenic syncope | Q33148289 | ||
| Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope | Q33148394 | ||
| Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. | Q33148932 | ||
| A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). | Q33151850 | ||
| Syncope Evaluation in the Emergency Department Study (SEEDS): a multidisciplinary approach to syncope management | Q33152048 | ||
| Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary | Q33152058 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 545-552 | |
| P577 | publication date | 2017-05-17 | |
| P1433 | published in | Journal of arrhythmia | Q26841910 |
| P1476 | title | Reflex syncope: Diagnosis and treatment | |
| P478 | volume | 33 |
| Q88876874 | Feasibility of a pilot intervention to reduce pain and syncope during adolescent vaccination | cites work | P2860 |
Search more.